TA
CUE icon

Teachers Advisors’s Cue Biopharma CUE Stock Holding History

Teachers Advisors’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$192K Buy
828
+90
+12% +$17.1K ﹤0.01% 2852
2018
Q4 		$104K Hold
738
– – ﹤0.01% 2948
2018
Q3 		$200K Hold
738
– – ﹤0.01% 2942
2018
Q2 		$263K Buy
738
+385
+109% +$153K ﹤0.01% 2912
2018
Q1 		$149K Buy
+353
New +$161K ﹤0.01% 2923

Other funds holding CUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Teachers Advisors's CUE Position: Q1 2019 in Review

Teachers Advisors increased its Cue Biopharma (CUE) stake by 12% in Q1 2019, buying an estimated $17.1K and bringing the position to 828 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #2852.

Teachers Advisors first reported a position in CUE in Q1 2018 and has held it in 5 quarters since. The position peaked at $263K in Q2 2018. 38 funds tracked by Wall St. Rank hold CUE as of Q1 2019.

  • Teachers Advisors held 828 shares of Cue Biopharma worth $192K as of Q1 2019.
  • Teachers Advisors bought 90 Cue Biopharma shares in Q1 2019, an estimated $17.1K.
  • Cue Biopharma made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2852 holding.
  • Teachers Advisors first reported a position in Cue Biopharma in Q1 2018 and has held it in 5 quarters since.
  • Teachers Advisors's Cue Biopharma position peaked at $263K in Q2 2018.
  • 38 funds tracked by Wall St. Rank held Cue Biopharma as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.